Passed House·Last action 1 day ago

HR2319 Boosts Lung Cancer Research for Women

Officially: Women and Lung Cancer Research and Preventive Services Act of 2025

HR2319 directs a review of lung cancer research focused on women and underserved groups. Affects women by improving screening and awareness.

Where it stands

Passed House. Now before the Senate.

This is the moment to act.

What this bill actually does

Interagency review: Conducts a review of lung cancer research focused on women and underserved groups.
Report to Congress: Requires a report with findings and recommendations within two years.

↓ Why your message matters here

This bill passed the House and is now before the Senate — this is the moment to act.

The debate

What people are saying about this bill

✓Arguments in support

Addresses disparities: The bill focuses on closing research gaps for women and underserved groups, who often face different risk factors and outcomes in lung cancer.
Improves access: By recommending expanded screening strategies, the bill aims to reduce late-stage diagnoses in underserved populations.
Enhances awareness: Public campaigns mandated by the bill could increase early detection rates, particularly in communities with low awareness.

✕Arguments against

Potential duplication: Critics might argue that the review overlaps with existing efforts by agencies like the NIH and CDC, potentially wasting resources.
Lacks direct action: The bill only produces recommendations, not immediate changes, which could delay help for those in need.
Narrow focus: Some might say the bill's focus on women and underserved groups overlooks broader lung cancer issues.

Where this bill is in the process

Legislative timeline

✓

Introduced

Introduced in House

—

✓

House Committee

Under House committee consideration

—

✓

House Floor Vote

Voted on by House

—

●

Passed House

Approved by House

Latest: Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (4/21/2026)

APR 21

○

Senate Review

Sent to Senate for consideration

—

○

Passed Both Chambers

Approved by both House and Senate

—

○

Signed into Law

Signed by the President

—

For more detail

Menu

HR2319 Boosts Lung Cancer Research for Women

What people are saying about this bill

Legislative timeline

Read deeper